Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET

American Journal of Psychiatry

Volumn 158, Issue 8, 2001, Pages 1206-1214

  Sekine, Y ^a   Iyo, M ^a   Ouchi, Y ^a   Matsunaga, T ^a   Tsukada, H ^a   Okada, H ^a   Yoshikawa, E ^a   Futatsubashi, M ^a   Takei, N ^a   Mori, N ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE TRANSPORTER; METHAMPHETAMINE;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; HUMAN; MALE; MENTAL DISEASE; NUCLEUS ACCUMBENS; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; SCORING SYSTEM;

ADULT; BEHAVIOR, ADDICTIVE; BRAIN CHEMISTRY; BRIEF PSYCHIATRIC RATING SCALE; CARBON RADIOISOTOPES; CARRIER PROTEINS; CAUDATE NUCLEUS; CEREBELLAR CORTEX; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PSYCHOSES, SUBSTANCE-INDUCED; PUTAMEN; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034888325     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.8.1206     Document Type: Article

References (47)

1. Amphetamine use: Return of an old scourge in a consultation psychiatry setting
2. Psychophysiological aspects of amphetamine-methamphetamine abuse
3. Use and abuse of amphetamines in Japan
4. Human methamphetamine-related fatalities in Taiwan during 1991-1996
5. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia
6. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan: A preliminary report
7. Methamphetamine-associated obsessional symptoms and effective risperidone treatment: A case report
8. Chronic psychotic illness from methamphetamine
9. Amphetamine psychosis: Clinical variations of the syndrome
10. Dopaminomimetic psychosis in Parkinson's disease patients: Diagnosis and treatment
11. Dopamine in schizophrenia: A review and reconceptualization
12. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
13. Mechanisms of biogenic amine neurotransmitter transporters
14. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
15. 11C]WIN-35,428
16. 3H]WIN 35,428
17. The brief psychiatric rating scale
18. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia
19. Bromocriptine in the prevention of alcohol abuse
20. Development of a high resolution PET
21. Measurement of acetylcholinest-erase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease
22. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for β-CFT binding with positron emission tomography
23. 2-dopamine receptors by PET
24. Drug induced psychosis
25. 3H]GBR-12935 binding after chronic treatment with dopamine active drugs
26. Brain dopamine transporter: Gender differences and effect of chronic haloperidol
27. Pharmacological effects of methamphetamine and other stimulants via inhalation exposure
28. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride
29. Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry
30. Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum: Evidence for a lobular- and laminar-specific dopamine innervation
31. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations
32. Neurochemical mechanisms of toxicity
33. Localization of drug reward mechanisms by intracranial injections
34. 2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography
35. Effects of chronic cocaine abuse on postsynaptic dopamine receptors
36. Dopamine transporters decrease with age
37. Iodine-123-N-omega-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease
38. Psychiatric syndromes in Huntington's disease
39. The behavioural and motor consequences of focal lesions of the basal ganglia in man
40. Prediction of detached personality in healthy subjects by low dopamine transporter binding
41. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections
42. Modification of dopamine transporter function: Effect of reactive oxygen species and dopamine
43. Neurochemistry of amphetamine
44. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders
45. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression
46. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients